Ameriprise’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2M Sell
465,602
-86,394
-16% -$1.36M ﹤0.01% 2545
2025
Q4
$10.1M Buy
551,996
+30,125
+6% +$508K ﹤0.01% 1899
2025
Q3
$7.65M Sell
521,871
-95,223
-15% -$1.63M ﹤0.01% 2109
2025
Q2
$11.2M Sell
617,094
-56,049
-8% -$1.14M ﹤0.01% 1725
2025
Q1
$13.4M Sell
673,143
-42,529
-6% -$736K ﹤0.01% 1563
2024
Q4
$12.3M Buy
715,672
+88,542
+14% +$1.67M ﹤0.01% 1651
2024
Q3
$12.5M Buy
627,130
+504,357
+411% +$7.84M ﹤0.01% 1623
2024
Q2
$1.37M Sell
122,773
-96,765
-44% -$812K ﹤0.01% 3024
2024
Q1
$1.45M Sell
219,538
-128,870
-37% -$704K ﹤0.01% 3020
2023
Q4
$1.57M Sell
348,408
-70,932
-17% -$262K ﹤0.01% 2992
2023
Q3
$1.5M Buy
419,340
+16,634
+4% +$64K ﹤0.01% 2962
2023
Q2
$1.49M Buy
402,706
+32,844
+9% +$122K ﹤0.01% 3018
2023
Q1
$1.22M Sell
369,862
-370
-0.1% -$1.28K ﹤0.01% 3067
2022
Q4
$1.44M Sell
370,232
-3,924
-1% -$12.1K ﹤0.01% 2955
2022
Q3
$910K Sell
374,156
-11,417
-3% -$27.4K ﹤0.01% 3156
2022
Q2
$764K Buy
+385,573
New +$759K ﹤0.01% 3227
2021
Q1
Sell
-21,400
Closed -$44K 3831
2020
Q4
$44K Sell
21,400
-27,280
-56% -$57.3K ﹤0.01% 3729
2020
Q3
$116K Buy
48,680
+2,270
+5% +$6.22K ﹤0.01% 3625
2020
Q2
$136K Buy
46,410
+14,110
+44% +$40.5K ﹤0.01% 3551
2020
Q1
$93K Buy
32,300
+8,700
+37% +$30.1K ﹤0.01% 3541
2019
Q4
$94K Sell
23,600
-22,405
-49% -$97.7K ﹤0.01% 3645
2019
Q3
$205K Sell
46,005
-3,395
-7% -$14.2K ﹤0.01% 3548
2019
Q2
$191K Buy
+49,400
New +$218K ﹤0.01% 3593

Other funds holding ADMA